- About
- 4624
Company Profile
Shenzhen Huian Bioscitech Co., Ltd. was established in April 2004. Headquartered in Shenzhen—a city of innovation and dreams—the company specializes in the development, production, sales, and service of in-vitro diagnostic medical devices.
Company Highlights
A professional and efficient technical and expert team
Comprehensive facilities for office, production, R&D, sales, warehousing, and quality assurance
Complete industry certifications: NMPA GMP & SGS ISO 13485:2016
National High-Tech Enterprise | Shenzhen “Specialized, Refined, Unique & New” SME | Shenzhen Innovative SME
Core Products
The “Q-yianni®” series of point-of-care testing (POCT) products:
45 CE-Certified Items
Covering infectious diseases, infections, cardiac conditions, digestive tract disorders, gynecological diseases, autoimmune & coagulation disorders.
31 NMPA-Approved Items
Same wide clinical menu, ensuring regulatory compliance in China.
Core Technologies
Monoclonal antibody technology, colloidal gold technology, double-antibody sandwich technology, and lateral-flow immunoassay technology converge into our proprietary Gold Immunoassay Lateral Flow Assay (GILFA) platform.
Global Footprint
Present in 32 provinces/municipalities across China and 21 countries & regions worldwide, Huian is committed to delivering high-quality products and efficient services that enable rapid diagnosis and treatment, alleviate suffering, and promote healthier lives.